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Acremonium chrysogenum is an important ﬁlamentous fungus which produces cephalosporin C in in-
dustry. This review summarized the study on genetic engineering of Acremonium chrysogenum, including
biosynthesis and regulation for fermentation of cephalosporin C, molecular techniques, molecular
breeding and transcriptomics of Acremonium chrysogenum. We believe with all the techniques available
and full genomic sequence, the industrial strain of Acremonium chrysogenum can be genetically modiﬁed
to better serve the pharmaceutical industry.
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Acremonium chrysogenum, belongs to Filamentous fungi, is an
important industrial microorganism. One of its metabolites, ceph-
alosporin C (CPC), is the major resource for production of 7-amino
cephalosporanic acid (7-ACA), an important intermediate for
manufacturing of many ﬁrst-line anti-infectious cephalosporins-
antibiotics, in industry.
Cephalosporins belong to the family of beta-lactam antibiotics.
Compared with the ﬁrst-discovered penicillin, cephalosporins have
obvious advantages since they are more resistant to penicillinaseng by Elsevier B.V. on behalf of KeAand are more effective to many penicillin-resistant strains. The
incidence of adverse effects for cephalosporins is also lower than
that for penicillins and other anti-infectious agents. Thus, cepha-
losporins are among the most-widely used anti-infectious drugs in
clinic.
In China, the research & development of cephalosporins started
from 1960s, and cefoxitinwas ﬁrst developed in 1970. In the past 40
years, cephalosporins-antibiotic is one of the most developed
medicines in Chinese market. It counts for more than 40% of the
anti-infectious market share.
As the major resource for manufacturing 7-ACA, the production
and cost of CPC is of the utmost importance for the cephalosporins-
antibiotic market. The Ministry of Science and Technology of China
has listed the fermentation of CPC as the key scientiﬁc and technical
projects during the past 30 years due to the continuous demandingi Communications Co. This is an open access article under the CC BY-NC-ND license
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chrysogenum.
Because of the limitation of traditional techniques on strain
improvement for A. chrysogenum, along with the ubiquitous ap-
plications of molecular biology, genetic engineering has become a
powerful tool to manipulate the antibiotic producing strain and to
obtain high-yield mutant strain.
This year, we will celebrate the 90th birthday of Dr. Arnold
Demain, the leader of b-lactam antibiotics research and develop-
ment [1]. This review will focus on the study of genetic engineering
of A. chrysogenum in our lab and other groups to memorize the
achievements of Dr. Demain's contribution in this ﬁeld.
2. Biosynthesis of CPC
The industrialization of CPC fermentation has been established
years ago with the breakthrough in key technologies including
fermentation yield, fermentation regulation and preparation &
puriﬁcation. Dr. Arnold Demain is truly a pioneer and a founder in
discovering the biosynthesis of CPC [2,3] such as stimulation by
methionine [4] and its precursors [5]. Nevertheless, there are still a
lot of recent publications on improvement of CPC-producing strain
by traditional methods, such as UV [6] or NTG [7] mutagenesis, and
optimization of fermentation process [8]. More recently, glycerol
was found can be used in the fermentation broth [9,10] replacing
methionine that Dr. Arnold Demain used decades ago, to stimulate
the biosynthesis of CPC. Researchers also tried solid-state and
submerged fermentation of CPC [11] besides the traditional pro-
duction. However, most of the latest strain breeding techniques are
at molecular level. And the most important approach is the
research on biosynthesis of the target metabolite.
Demain's group has studied on the role of methionine in the
fermentation of CPC [12]. Methionine can stimulation the produc-
tion of CPC in the crude media, and the addition of methionine was
still kept in current A. chrysogenum fermentation. They found that
methionine does not repress or inhibit cysteine metabolism.
Although methionine can upregulate the transcriptions of pcbAB,
pcbC and cefEF, and stimulates the mycelial fragmentation, the
mechanism behind the fact still needs to be investigated [13,14].
The biosynthesis of CPC during the fermentation of
A. chrysogenum has been well elucidated now. There are two gene
clusters on the chromosome that involved in the biosynthesis of
CPC. The “early” cluster consists of pcbAB-pcbC and cefD1-cefD2.
pcbAB-pcbC encode two enzymes responsible for the ﬁrst two steps
in CPC biosynthesis [15]. cefD1-cefD2 encode proteins that epi-
merize IPN to penicillin N [16]. The “late” cluster consists of cefEF
and cefG, which encode enzymes responsible for the last two steps
[17].
The biosynthesis pathway of CPC is illustrated in Fig. 1. ACV
synthase, encoded by pcbAB, condense 3 precursors including L-a-
aminoadipic acid, L-cysteine, L-valine to ACV tripeptide. A
comprehensively written review on this enzyme was published by
Zhang & Demain in 1991 [18]. In Streptomyces clavuligerus, Lysine
ε-aminotransferase (LAT) is also within the early gene cluster for
cephamycin C biosynthesis. Since cephamycin C shares most of the
biosynthetic genes with CPC biosynthesis pathway, it has been
studied extensively by Demain's group [19e21].
ACV is then cyclized into isopenicillin N (IPN) by IPN synthase
encoded by pcbC. Conversion from IPN to penicillin N was catalyzed
by a two-component epimerization system encoded by cefD1-
cefD2. cefEF encodes a unique bi-functional enzyme, deacetyloxy-
cephalosporin C (DAOC) synthase-hydroxylase which successively
transforms penicillin N into DAOC and deacetyl-cephalosporin C
(DAC). The last step in CPC biosynthesis is catalyzed by DAC-
acetyltransferase (DAC-AT) which was encoded by cefG. Thecrystal structure of DAC-AT has been published. It was found that
DAC-AT belongs to a/b hydrolase family based on the formation of
DAC-enzyme complex [22]. Among these enzymological steps,
pcbAB, cefEF and cefGwere considered as the rate-limiting factors in
CPC biosynthesis [23].
Recent years, some other regulatory proteins, which have been
found important in CPC biosynthesis, as well as their coding genes
were discovered. For example, AcveA, a homologue of veA from
Aspergillus, regulates the transcription of all six major CPC biosyn-
thesis genes including pcbAB, pcbC, cefD1, cefD2, cefEF and cefG.
Disruption of AcveA leads to a dramatic reduction of CPC yield [24].
We also tried overexpression of AcveA and the production of CPC
was increased, as expected, by 22.7%. The transcriptions of pcbC,
cefEF and cefG were all upreglated [25].
A cefP gene located in the early cluster of CPC biosynthesis
cluster was just characterized. This gene encodes a transmembrane
protein anchored on peroxisome. It regulates the epimerization of
IPN to penicillin N catalyzed by CefD1-CefD2 two-component
enzyme complex in peroxisome. cefP disruptant accumulated IPN
and lost CPC production [26]. To compensate the disruption of cefP,
cefP and cefR are necessary to be introduced simultaneously. CefR is
the repressor of CefT, and stimulate the transcription of cefEF. The
cefR knock out mutant showed a delayed transcription of cefEF and
accumulation of penicillin N results in reduction of CPC yield [27].
A cefM gene was also found downstream of cefD1. Disruption of
cefM accumulates penicillin N but no CPC production at all [28]. It is
suggested that CefMmay involve in the translocation of penicillin N
from peroxisome to cytoplasm. Without cefM, cells are unable to
transport penicillin N which is epimerized in peroxisome into
cytoplasm, where CPC is synthesized.
3. Genetic engineering of Acremonium chrysogenum
Acremonium chrysogenum belongs to the family of Filamentous
fungi. The techniques for genetic engineering are somehow hard to
develop due to its complicate structure of cell wall and the special
life cycle. Our lab has started the study of A. chrysogenum at mo-
lecular level based on some published results from host, trans-
formation, homologous recombination and selection marker of
A. chrysogenum [29,30].
To introduce exogenous DNA into A. chrysogenum, a traditional
PEGmediated protoplast transformationmethod is commonly used
[31]. Since we are focusing on high-yield, or industrial strains,
which usually have a stronger restriction-modiﬁcation system than
wide-type strain, the traditional transformation method is not
efﬁcient enough for introduction of exogenous genes.
Agrobacterium tumefaciens mediated transformation has been
widely used in plant genetic engineering, and in some of the Fila-
mentus fungi including Penicillium chrysogenum and Aspergillus
nidulans as well. We have developed an adapted A. tumefaciens
mediated transformation protocol for A. chrysogenum, which has a
higher transformation efﬁciency than the PEG mediated method
[32], and more importantly, this protocol can also be applied in
A. chrysogenum high-yield strain. This is the ﬁrst report of
A. tumefaciens mediated A. chrysogenum transformation.
A lot of basic research was done to facilitate the genomic DNA
extraction [33] and endogenous promoter capture [34] from the
chromosome of A. chrysogenum. A notable progress is the cloning of
pcbAB-pcbC bi-directional promoter from the chromosome of
A. chrysogenum [35]. This enables convenient manipulation of
A. chrysogenum by introduction of multiple genes afterwards.
Two inducible endogenous promoter Pmir1 [36] and Pxyl1 [37]
were identiﬁed to be suitable for conditional expression in
A. chrysogenum. These approaches not only provide the efﬁcient
tools for genetic engineering of A. chrysogenum, but also make it
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few selection markers are applicable in this Filamentus fungus.
The exogenous promoter Smxyl from Sordariamacrospore can also
be used to construct the selection marker free recombinant mutant
by using AcKu70 knock out strain as the recipient, and one step FLP/
FRT recombinant systemwas successfully introduced to facilitate the
genetic engineering of A. chrysogenum. This process can insert the
exogenous gene into the genome of the CPC-producing strain
without addition of the antibiotic-resistant gene [38].
Besides the introduction of exogenous genes, disruption and/or
silencing of the endogenous genes is also a common strategy for
genetic breeding of a certain strain. The recently developed RNA
interference (RNAi) technique can be used as an alternative to
silence the transcription of target genes instead of homologous
recombination. RNAi in A. chrysogenumwas ﬁrst published in 2007
[39]. The latest report was silencing of pcbC gene in Penicilliumchrysogenum and cefEF gene in A. chrysogenum by RNAi [40]. These
reports demonstrated the feasibility of RNAi technique in the Fila-
mentous fungi.
We also tried the RNAi technique in A. chrysogenum. A plasmid
vector containing cefG double strand RNA transcription unit was
constructed and transformed into CPC-producing A. chrysogenum.
The cefG transcription level in the transformants was measured by
quantitative RT-PCR. The cefG transcription level decreases to 20%
in twomutant strains. Their CPC yieldwas also found to decrease by
34.6% and 28.8%, respectively [41]. This result demonstrated the
feasibility of RNAi application in A. chrysogenum and possible, in-
dustrial strain. Moreover, this is important for metabolic pathway
reconstitution and novel CPC derivatives fermentation in
A. chrysogenum.
By using the techniques that have been developed, researchers
are able to study gene function in vivo to elucidate their impact on
Y. Hu, B. Zhu / Synthetic and Systems Biotechnology 1 (2016) 143e149146CPC production in A. chrysogenum. A glutathione reductase coding
gene glrA was knocked out in A. chrysogenum, and the activity of
glutathione reductase was disrupted leading to the accumulation of
glutathione disulﬁde. This mutant is sensitive to oxygen stress and
produces non-detectable cephalosporins. Overexpression of glrA
can restore the glutathione reductase activity and the ratio of GSH/
GSSR. The growth and CPC production can also be recovered by
addition of methionine [42]. Similarly, a thioredoxin reductase-
encoding gene ActrxR1 was also knocked out and spore germina-
tion and hyphal growth were inhibited. However, addition of DL-
methionine can restore the delay and CPC production was
enhanced, as well as the transcription of pcbC, cefEF and cefG [43].
The fungal nitrogen regulatory GATA zinc-ﬁnger protein AcareA
was disrupted in A. chrysogenum and the mutation causes the
reduction of CPC production. Meanwhile, transcriptions of CPC
biosynthetic genes including pcbAB, cefD2, cefEF and cefG were
downregulated. AcareA binds not only to the promoter region of
nitrate reductase gene niaD-niiA, but also to the bidirectional pro-
moter of pcbAB-pcbC [44].
Impaired growth mutant of A. chrysogenumwas analyzed and a
partial deleted putative septation protein encoding gene AcsepH
was identiﬁed. Absence of AcsepH leads to reduction of septation
and formation ofmultinucleate cells inA. chrysogenum. Also, conidia
and CPC production was signiﬁcantly decreased along with delay
and decreased transcriptions of pcbC, cefD1, cefD2 and cefEF [45].
Acatg1 is a homolog of eukryotic serine/threonine kinase
involved in autophagy. Disruption of Acatg1 in A. chrysogenum
signiﬁcantly reduces the formation of conidia, similar to disruption
of AcsepH. However, CPC production was surprisingly enhanced in
the Acatg1 disruption mutant and PcbC expressionwas kept at high
level all through the fermentation process [46].
Our lab cloned a putative thiazole biosynthesis gene Acthi and
found knock out of Acthi in A. chrysogenum reduced the intracel-
lular concentration of thiamine and CPC biosynthesis precursor
amino acids, while the formation of conidia was also decreased.
Overexpression of Acthi can restore the reduction, upregulate the
transcriptions of CPC biosynthetic genes and increase the produc-
tion of CPC [47].
4. Omics study of Acremonium chrysogenum
Recent years, researchers have started genetic engineering of
A. chrysogenum at the omics level by comparing the high yield
strain with the low yield strain. Scientists from Russia used qPCR to
detect the transcriptional level of CPC biosynthesis related genes in
a high-producing strain RNCM F-4081D and the wide-type strain
ATCC 11550 [48]. Results revealed that regulatory genes cefM and
cefR were upregulated in the CPC high-producing strain. All
biosynthetic genes including pcbAB, pcbC, cefD1, cefD2, cefEF and
cefG had signiﬁcantly higher transcriptional levels in RNCM F-
4081D strain, which produces 100-fold more CPC than the wide-
type strain. Although these results are anticipated, the balanced
transcriptions of the biosynthetic genes and regulatory genes could
give us some ideas to improve CPC production in A. chrysogenum.
We have studied the proteomics [49] and transcriptomics of an
industrial CPC-producing strain (high-yield, HY) and the wide-type
(WT) strain. According to comparative proteomics results, several
signiﬁcantly differentially expressed proteins including Acthi were
identiﬁed. Comparative transcriptomics study revealed more in-
formation. A total of 4329 genes were identiﬁed that have signiﬁ-
cantly differential transcription levels in which 1737 were
upregulated and 2592 were downregulated in HY strain [50]. These
differentially expressed genes belong to the pathways of carbohy-
drate metabolism and energy, defense and virulence mechanisms,
CPC biosynthetic precursor amino acids, oxidative stress defenses,and other secondary metabolites.
We also looked at the transcriptional level of some key genes
involved in the primary metabolism in A. chrysogenum, which
haven't been systemically studied as well as its correlationwith CPC
production to date. Glycolysis and gluconeogenesis, TCA cycle and
Glyoxylate cycle, Pentose phosphate pathway and GABA shunt, and
serine, lysine, cysteine, valine biosynthesis were studied and ﬁve
important intermediates including glucose 6-phosphate, 3-
phosphoglycerate, pyruvate, malate and succinate were identiﬁed.
The involved metabolic pathways showed shifted ﬂows which are
favorable for switching to CPC production in HY strain [51]. These
are very important information for future metabolic engineering of
the CPC-producing A. chrysogenum.
Without the genomic sequence, omics study gave us the overall
proﬁle of the CPC-producing A. chrysogenum. Not surprisingly, this
important industrial strain was sequenced recently, and the full
genomic sequence was publicly revealed [52]. The sequence
showed it has about 28.6 Mb in length, and approximately 8901
coding regions. However, this is shorter than the estimation of
32.7 Mb before [53]. Also the sequenced strain is the wide-type
ATCC 11550. Lots of gaps are still open in the sequence. This also
drew our attentions because there are several genes identiﬁed in
our transcriptome study were not found in the published sequence,
including Acthi.
The published genome also contains the mitochondrial
sequence, which was published by other researchers elsewhere.
This 27 Kb circular molecule contains 19 coding regions and 26
tRNA genes. Interestingly, all genes are located on one strand and
may transcribed in the same direction [54]. Publication of both the
chromosomal and mitochondrial sequences, as well as the tran-
scriptome and proteome study will boost the genetic engineering
of this important Filamentus fungus.
5. Molecular breeding of Acremonium chrysogenum
Among the three rate-limiting enzyme, PcbAB is relatively
difﬁcult to manipulate due to its larger coding region. Thus, re-
searchers focus on cefEF and cefG for molecular breeding of
A. chrysogenum. Besides, extra copy numbers of cefT could increase
the yield of CPC in A. chrysogenum [55]. And, overexpression of cefP
and cefR in A. chrysogenum can decrease the accumulation of
penicillin N and promote the yield of CPC by about 50% [27].
The fermentation process of A. chrysogenum is an extreme
oxygen-consuming procedure. All the rate-limiting enzymes are
oxygen-requiring enzymes. The Vitreoscilla Hemoglobin (VHb) is
very attractable since it's capable of oxygen transmission in
oxygen-limiting environment. A recombinant strain bearing VHb
can signiﬁcantly improve the usage of oxygen during the fermen-
tation process and increase the product yield, which has been
proved in Aspergillus [56]. Introduction of vgb, the coding gene for
VHb, into A. chrysogenum can also maintain a higher speciﬁc
growth rate and speciﬁc production rate resulted in a 4e5 fold
higher yield of the mutant strain [57]. Actually, there are many
industrial A. chrysogenum strains that have recombinant vgb.
The earliest report on genetic modiﬁcation for A. chrysogenum
was published in 1989, when researchers from Eli Lilly Co. intro-
duced extra copy of cefEF-cefG fragment into A. chrysogenum
resulted in a 15%e40% higher producing strain [58]. This is the ﬁrst
evidence that molecular breeding can be a powerful tool in strain
improvement of A. chrysogenum.
Although controlled by the same bi-directional promoter, the
transcription levels of cefEF and cefG showed a huge difference
according to RT-PCR. The transcription of cefG is much lower than
that of cefEF. This leads to the accumulation of DAC in the metab-
olites since they can not be efﬁciently transformed into CPC. As a
Table 1
Manipulated genes in CPC low/high producers and their inﬂuence on yield.
Gene Manipulation Producer CPC yield Reference
AcveA Knock out low decrease [24]
AcveA overexpression low increase [25]
cefP Knock out low None [26]
cefR Knock out low decrease [27]
cefP/cefR overexpression low increase [27]
cefM Knock out Low decrease [28]
cefEF Knock down low decrease [40]
cefG Knock down low decrease [41]
glrA Knock out low none [42]
ActrxR1 Knock out low delay [43]
AcareA Knock out low decrease [44]
AcsepH Knock out low decrease [45]
Acatg1 Knock out low increase [46]
Acthi Knock down low/high decrease [47]
Acthi overexpression low/high increase [47]
cefT overexpression low increase [55] [60]
vgb overexpression low increase [57]
cefEF-cefG overexpression high increase [58]
cefG overexpression low increase [59]
cefG/vgb overexpression low/high increase [70]
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industrial production of CPC fermentation. Thus, introduction of
extra copy numbers of cefG produced an engineering strain whose
CPC yield is 3-fold-higher than the parental strain [59].
There is another report on introduction of cefT into
A. chrysogenum, and the resulting mutant doubled the CPC yield
[60]. This could attribute to the enhancement of CefT, the efﬂux
pump protein, so that the feedback inhibition in vivo triggered by
the fermentation product was attenuated, resulted in an elevated
product yield.
Using molecular breeding technology, some CPC derivatives can
be directly produced by engineering A. chrysogenum fermentation.
For example, by disruption of cefEF and introduction of cefE origi-
nated from Streptomyces clavuligerus, a novel DAOC producing
strain was obtained. Followed by two enzymatic transformations,
the industrial important 7-ADCA can be produced [61]. By intro-
duction of two coding genes simultaneously into A. chrysogenum
for the enzymes used in industrial production of 7-ACA by immo-
bilized enzymatic transformation, the engineering strain can pro-
duce 7-ACA by fermentation [62].
Only one enzyme (DAOC/DAC synthase) is responsible for syn-
thesis of deacetylcephalosporin C (DAC) from penicillin N. The
coding gene for DAOC/DAC synthase is cefEF in A. chrysogenum.
However, in Streptomyces clavuligerus (cephamycin C producer),
there are two enzymes responsible for this two step conversion
encoded by cefE and cefF. Introduction of cefF (coding for DAOC
hydroxylase) into A. chrysogenum can signiﬁcantly decrease the
DAOC/CPC ratio given that DAOC is a major impurity in the
fermentation of CPC production [63].
There is another interesting research for the molecular breeding
of A. chrysogenum in a different way. As we mentioned above,
CefD1-CefD2 is a two-component enzyme complex that transform
IPN into penicillin N by an epimerization system located in
peroxisome. cefD1-cefD2 block mutant lacking this epimerization
system accumulated a large amount of IPN tomore than 650 mg/mL,
almost the total relative CPC yield. The unstable IPN, which never
has been puriﬁed before, could be puriﬁed by several steps of
chromatography in this mutant [64]. Characterization of its half-life
and stability under variety conditions can greatly help us for the
investigation of IPN.
Genome shufﬂing [65] is a powerful tool for strain improvement
especially when lacking the genomic sequence of the target strain.
We have proved that this technique is also effective in
A. chrysogenum. By genetic engineering, we have constructed a
strain of A. chrysogenum that can directly produce 7-ACA by
fermentation, however, the yield is still low [66]. With the help of
genome shufﬂing, the yield of 7-ACA has been increased by 6.5 fold
by two round of screening [67]. This makes it potential possible to
manufacture 7-ACA, the important b-lactam intermediate, by one-
step A. chrysogenum fermentation instead of the current two-step
process which consist of fermentation of A. chrysogenum plus the
enzymatic transformation of CPC [68].
It's worth noting that all of the above genetic breeding reports
were on the background of an A. chrysogenum wide type strain,
whose CPC yield is only around 1mg/mL, far less than the industrial
production level, which is around 15e20 mg/mL in ﬂask and
35e40 mg/mL in fermentor. Although some great achievements
were obtained in improvement of A. chrysogenum fermentation and
modiﬁcation of metabolic products, those achievements are still far
away from application in industry.
6. Genetic engineering of industrial Acremonium
chrysogenum
Our research is focusing on molecular breeding ofA. chrysogenum high-yield and/or industrial strains. We introduced
different combinations of cefG/cefEF/cefT/vgb genes into CPC high-
producing strain and found that an extra copy of cefG has signiﬁ-
cant positive effect on CPC fermentation level. Since random inte-
gration was occurred in A. chrysogenum, different transformants
with cefG introduction showed different elevated levels, with 100%
promotion at most. An extra copy of vgb gene that had been under
directed evolution and had elevated bioactivity [69] also displayed
a signiﬁcant improvement up to 30%more of CPC yield. Meanwhile,
introduction of cefEF and cefT has no obvious effect on CPC pro-
duction in high-yield strain [70]. This revealed the apparent
discrepancy between the genetic background of wide-type strain
and high-yield strain, and also suggested that endogenous cefEF
and cefT may already achieve high bioactivity after several rounds
of mutagenesis breeding that a high-yield strain usually
undertaken.
We then applied this achievement to a CPC industrial strain.
Although we couldn't double the CPC yield, we did obtain an en-
gineering strainwhose CPC yield was increased by 20%, which has a
promising industrialization potential. See Table 1 for a complete list
of genes that have beenmanipulated in A. chrysogenum (low or high
producers) and their inﬂuence on CPC yield.
The fermentation product of A. chrysogenum, CPC, is the major
resource for industrial manufacturing of 7-ACA, the important in-
termediate of a large variety of cephalosporins antibiotics. A
traditional producing route of 7-ACA is the chemical semi-
biosynthesis. Up to date, the more environmental-friendly
biotransformation has been widely used in industry. Two step
transformation using DAO (D-amino acid oxidase) and GL-7-ACA
acylase dominates the market for decades [71], more recently one
step transformation from CPC to 7-ACA by CPC acylase has become
available [72], although, the substrate speciﬁcity of CPC acylase still
need improved [73].
Whether two-step or one-step, fermentation of CPC is the pre-
requisite followed by enzymatic biotransformation in vitro. We are
thinking of introducing CPC acylase gene into A. chrysogenum to
construct the engineering strain that can produce 7-ACA directly by
fermentation, a breakthrough in the production of 7-ACA.
A CPC acylase gene was designed according to the codon bias of
A. chrysogenum and introduced into an industrial strain. Our result
showed that this CPC acylase was expressed in A. chrysogenumwith
bioactivity. The recombinant acylase can transform the original
Y. Hu, B. Zhu / Synthetic and Systems Biotechnology 1 (2016) 143e149148product CPC into 7-ACA in vivo, whichmakes the engineering strain
capable of direct fermentation of 7-ACA. Based on enzymological
proﬁles of CPC acylase in vitro, we performed a preliminary opti-
mization of medium composition and culture condition. 7-ACA
yield was increased signiﬁcantly in this engineering strain with as
least 30% of the fermented CPC was transformed into 7-ACA [74].
We believe this in vivo conversion can be more effective if a
stronger transcription cassette can be introduced and copy number
can be increased. With the incorporation of traditional breeding
technology, in vivo conversion will be realized in industry.
7. Perspectives
The biosynthesis of CPC in A. chrysogenum has been investigated
thoroughly. However, themechanism of its regulation as well as the
precursor biosynthesis in primary metabolism is still unclear [75].
Full sequence of A. chrysogenum has been published, plus there are
more than 10 species belongs to Filamentous fungi have been
sequenced [76]. However, gaps need to be ﬁlled, and all genes need
to be annotated and studied to understand their in vivo functions.
With the information of the genes that have been published and
studied, we can manipulate the genome of A. chrysogenum more
efﬁciently. CRISPR/Cas9 is a powerful tool for genome editing in
animals [77] and mammalian cells [78] since its discovery.
Currently, this technique has been used in microorganisms
including E. coli [79], Streptomyces [80] and Yeast [81]. Although
Filamentous fungi is relative difﬁcult to genetically modify, we are
trying this system in A. chrysogenum in our lab. There are also some
publications on genome editing of Filamentous fungi such as
Aspergillus [82e84], Pyricularia [85], Trichoderma [86] and Penicil-
lium [87] in the recent two years. Thus, we believe it is possible to
edit the genome of A. chrysogenum by the newly developed system.
By identifying differentially expressed proteins during CPC
fermentation in wide-type strain and high-yield strain, a compre-
hensive regulation system of A. chrysogenum fermentation may be
proposed based on the popular theory of metabolic engineering
and systems biology [88] because omics study has shown to be a
powerful tool to study the metabolic pathway from a systemic
scope. A study on Penicillin chrysogenum revealed that 950 proteins
involved in precursor biosynthesis, stress response and pentose
phosphate pathway were found to be related to the fermentation
yield in three penicillin-producing strains [89]. We have identiﬁed
several differentially expressed proteins that are associated with
several metabolic pathways, especially those involved in primary
metabolism of A. chrysogenum. Study of these genes along with
their involved pathways is in progress and can help us better un-
derstand how the primary metabolism will inﬂuence the CPC
biosynthesis. Andwe believe this should incorporatemetabolomics
study [90] that helps us explain from the transcription and
expression to metabolism.
Dr. Demain opened up a new era ﬁfty years ago. Now, with the
help of modern molecular techniques and more powerful tools, we
believe that genetic modiﬁed Acremonium chrysogenumwill play an
important role in the industrial production of CPC and its
derivatives.
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